{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:58:26Z","timestamp":1787169506978,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.canlet.2025.217511","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T19:04:25Z","timestamp":1738091065000},"page":"217511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response"],"prefix":"10.1016","volume":"613","author":[{"given":"Peng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6311-2649","authenticated-orcid":false,"given":"Xue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217511_bib1","first-page":"1","article-title":"Treatment sequencing in resectable lung cancer: the good and the bad of adjuvant versus neoadjuvant therapy","volume":"42","author":"Provencio","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"11","key":"10.1016\/j.canlet.2025.217511_bib2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1200\/JCO.22.01990","article-title":"Pembrolizumab plus chemotherapy in squamous non-small-cell lung cancer: 5-year update of the phase III KEYNOTE-407 Study","volume":"41","author":"Novello","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217511_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2021.06.028","article-title":"PET\/CT metabolic patterns in systemic immune activation: a new perspective on the assessment of immunotherapy response and efficacy","volume":"520","author":"Jin","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2025.217511_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217511_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217272","article-title":"Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma","volume":"604","author":"Huang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217511_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216507","article-title":"Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma","volume":"582","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.canlet.2025.217511_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138740","article-title":"Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control","volume":"131","author":"Lhuillier","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.canlet.2025.217511_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.217511_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2025.217511_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002038","article-title":"Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?","volume":"9","author":"Demaria","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217511_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","article-title":"Interleukin-15 biology and its therapeutic implications in cancer","volume":"33","author":"Steel","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"96","key":"10.1016\/j.canlet.2025.217511_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk4893","article-title":"Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation","volume":"9","author":"Foltz","year":"2024","journal-title":"Sci Immunol"},{"issue":"46","key":"10.1016\/j.canlet.2025.217511_bib13","doi-asserted-by":"crossref","first-page":"E10915","DOI":"10.1073\/pnas.1811615115","article-title":"IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.canlet.2025.217511_bib14","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.4049\/jimmunol.1102604","article-title":"Augmented IL-15R\u03b1 expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in mice","volume":"188","author":"Zhang","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217511_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1553","article-title":"Combining TIGIT blockade with IL-15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma","volume":"14","author":"Luo","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"12","key":"10.1016\/j.canlet.2025.217511_bib16","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.4049\/jimmunol.1303175","article-title":"The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages","volume":"193","author":"Gillgrass","year":"2014","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.canlet.2025.217511_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-21-0058","article-title":"An Engineered IL15 cytokine mutein fused to an Anti-PD1 improves intratumoral T-cell function and antitumor immunity","volume":"9","author":"Xu","year":"2021","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217511_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2025.217511_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1084\/jem.20061805","article-title":"Antiviral CD4+ memory T cells are IL-15 dependent","volume":"204","author":"Purton","year":"2007","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.canlet.2025.217511_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.canlet.2025.217511_bib21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2003-08-2814","article-title":"Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells","volume":"103","author":"Schluns","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.canlet.2025.217511_bib22","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20071913","article-title":"IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation","volume":"205","author":"Mortier","year":"2008","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.canlet.2025.217511_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.1814642116","article-title":"IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses","volume":"116","author":"Santana Carrero","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.canlet.2025.217511_bib24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/2326-6066.CIR-19-0338","article-title":"Radiotherapy cooperates with IL15 to induce antitumor immune responses","volume":"8","author":"Pilones","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"589","key":"10.1016\/j.canlet.2025.217511_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd9882","article-title":"Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma","volume":"13","author":"Murakami","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2025.217511_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216892","article-title":"Anlotinib enhanced CD8(+) T cell infiltration via induction of CCL5 improves the efficacy of PD-1\/PD-L1 blockade therapy in lung cancer","volume":"591","author":"Luo","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2025.217511_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000599","article-title":"Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-\u03b3, CXCL9 and CXCL10","volume":"8","author":"Bergamaschi","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217511_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/eji.200425577","article-title":"Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5\/RANTES and CXCL10\/IP-10 expression","volume":"35","author":"Chen","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217511_bib29","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.1101883","article-title":"IL-15 can signal via IL-15R\u03b1, JNK, and NF-\u03baB to drive RANTES production by myeloid cells","volume":"188","author":"Chenoweth","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.canlet.2025.217511_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007725","article-title":"First-in-human phase I\/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15R\u03b1, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors","volume":"11","author":"Leidner","year":"2023","journal-title":"J Immunother Cancer"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:57:15Z","timestamp":1760741835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S0304383525000758"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217511","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic enhancement of radio-immunotherapy efficacy by IL-15 via macrophage activation and memory T cell response","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217511"}}